PARIS–(BUSINESS WIRE)–#biotech–Inotrem, a company specialized in immunotherapy, announces positive results from the Phase IIa study of its lead compound in septic shock patients.
In a Nursing Open study, peer relations
In a new joint policy statement,
© 2017 Worldnews Media LLC. All Rights Reserved.